Pfizer Inc.
Registered Principal Details
Business Or Interest:
Pharmaceutical manufacturing and healthcare.
Lobbying Interests:
All matters affecting the pharmaceutical manufacturing and healthcare industries
CEO Name:
Albert Bourla
Pharmaceutical manufacturing and healthcare.
Lobbying Interests:
All matters affecting the pharmaceutical manufacturing and healthcare industries
CEO Name:
Albert Bourla
Contact
JD
James DeMay
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815
Sausalito, CA 94965
(415) 903-2800
jskelton@politicomlaw.com
http://www.pfizer.com
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815
Sausalito, CA 94965
(415) 903-2800
jskelton@politicomlaw.com
http://www.pfizer.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|---|---|---|
| James DeMay | Exclusive Duties No | Authorized On 12/23/2022 | Withdrawn On 4/24/2023 |
| John Krueger | Exclusive Duties No | Authorized On 12/23/2022 | Withdrawn On 1/12/2023 |
| Tony Langenohl | Exclusive Duties No | Authorized On 1/9/2023 | Withdrawn On N/A |
| William J McCoshen | Exclusive Duties No | Authorized On 1/9/2023 | Withdrawn On N/A |
| Craig Gill | Exclusive Duties No | Authorized On 8/8/2024 | Withdrawn On N/A |
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 103
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
3/15/2023
First Communication Date
3/15/2023
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
For
Notification Date3/15/2023
First Communication Date
3/15/2023
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Assembly Bill 184
Relating to: providing additional information fields regarding occupation on death records.
Bill Text and History
7/27/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: providing additional information fields regarding occupation on death records.
Bill Text and History
For
Notification Date7/27/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 773
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
2/3/2024
First Communication Date
2/2/2024
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
For
Notification Date2/3/2024
First Communication Date
2/2/2024
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Assembly Joint Resolution 111
Relating to: observing February 29, 2024, as Rare Disease Day in Wisconsin.
Bill Text and History
2/3/2024
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: observing February 29, 2024, as Rare Disease Day in Wisconsin.
Bill Text and History
For
Notification Date2/3/2024
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 100
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
3/10/2023
First Communication Date
3/8/2023
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
For
Notification Date3/10/2023
First Communication Date
3/8/2023
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Senate Bill 737
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
2/3/2024
First Communication Date
2/2/2024
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
For
Notification Date2/3/2024
First Communication Date
2/2/2024
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Senate Joint Resolution 102
Relating to: observing February 29, 2024, as Rare Disease Day in Wisconsin.
Bill Text and History
2/3/2024
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: observing February 29, 2024, as Rare Disease Day in Wisconsin.
Bill Text and History
For
Notification Date2/3/2024
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Total Lobbying Effort
| 2023 January - June |
2023 July - December |
2024 January - June |
Total | |
|---|---|---|---|---|
| Total Lobbying Expenditures | 2023 January - June $32,021.63 |
2023 July - December $30,000.00 |
2024 January - June $30,000.00 |
Total $92,021.63 |
| Total Hours Communicating | 2023 January - June 4.00 |
2023 July - December 3.50 |
2024 January - June 12.00 |
Total 19.50 |
| Total Hours Other | 2023 January - June 45.00 |
2023 July - December 56.00 |
2024 January - June 58.50 |
Total 159.50 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: providing additional information fields regarding occupation on death records.
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 8% |
2023 July - December |
2024 January - June |
2024 July - December |
Total 2% |
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 35% |
2023 July - December 50% |
2024 January - June 20% |
2024 July - December |
Total 34% |
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 52% |
2023 July - December 50% |
2024 January - June 20% |
2024 July - December |
Total 39% |
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June |
2023 July - December |
2024 January - June 30% |
2024 July - December |
Total 12% |
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June |
2023 July - December |
2024 January - June 30% |
2024 July - December |
Total 12% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
No topics found.
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
No other matters found.